Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103844203 | 10384420 | 3 | F | 20140403 | 20160926 | 20140814 | 20160928 | EXP | DE-ROCHE-1446713 | ROCHE | 45.00 | YR | F | Y | 72.00000 | KG | 20160928 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103844203 | 10384420 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 125409 | 840 | MG | SOLUTION FOR INFUSION | Q3W | |||||||
| 103844203 | 10384420 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE: 16/NOV/2015 | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | 576 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 4 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | 432 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 5 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | 430 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 6 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | 410 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 7 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | 430 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 103844203 | 10384420 | 8 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | Y | 0 | 135 | MG | Q3W | |||||||
| 103844203 | 10384420 | 9 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | LAST DOSE: 16/NOV/2015 | Y | 0 | 130 | MG | Q3W | ||||||
| 103844203 | 10384420 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 103844203 | 10384420 | 11 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 103844203 | 10384420 | 12 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 0 | 10 | MG | BID | ||||||||
| 103844203 | 10384420 | 13 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | QD | ||||||||
| 103844203 | 10384420 | 14 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 103844203 | 10384420 | 15 | C | LONQUEX | LIPEGFILGRASTIM | 1 | Subcutaneous | DAY 2 | 0 | 6 | MG | Q3W | |||||||
| 103844203 | 10384420 | 16 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Oral | 0 | 8 | MG | BID | ||||||||
| 103844203 | 10384420 | 17 | C | KEVATRIL | GRANISETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 1 | MG | QD | ||||||||
| 103844203 | 10384420 | 18 | C | MCP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103844203 | 10384420 | 1 | Breast cancer metastatic |
| 103844203 | 10384420 | 3 | Breast cancer metastatic |
| 103844203 | 10384420 | 8 | Breast cancer metastatic |
| 103844203 | 10384420 | 10 | Hypertension |
| 103844203 | 10384420 | 11 | Hypertension |
| 103844203 | 10384420 | 12 | Tachycardia |
| 103844203 | 10384420 | 13 | Depression |
| 103844203 | 10384420 | 14 | Depression |
| 103844203 | 10384420 | 15 | Prophylaxis |
| 103844203 | 10384420 | 16 | Vomiting |
| 103844203 | 10384420 | 17 | Vomiting |
| 103844203 | 10384420 | 18 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103844203 | 10384420 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103844203 | 10384420 | Dizziness | |
| 103844203 | 10384420 | Erysipelas | |
| 103844203 | 10384420 | General physical health deterioration | |
| 103844203 | 10384420 | Mucosal inflammation | |
| 103844203 | 10384420 | Nausea | |
| 103844203 | 10384420 | Neuropathy peripheral | |
| 103844203 | 10384420 | Tachycardia | |
| 103844203 | 10384420 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103844203 | 10384420 | 1 | 20140331 | 20140331 | 0 | |
| 103844203 | 10384420 | 2 | 20140422 | 0 | ||
| 103844203 | 10384420 | 3 | 20140331 | 20140331 | 0 | |
| 103844203 | 10384420 | 4 | 20140422 | 20140512 | 0 | |
| 103844203 | 10384420 | 5 | 20140604 | 20140604 | 0 | |
| 103844203 | 10384420 | 6 | 20140630 | 20140630 | 0 | |
| 103844203 | 10384420 | 7 | 20140721 | 0 | ||
| 103844203 | 10384420 | 8 | 20140331 | 20140331 | 0 | |
| 103844203 | 10384420 | 9 | 20140422 | 0 | ||
| 103844203 | 10384420 | 10 | 2011 | 0 | ||
| 103844203 | 10384420 | 11 | 2011 | 20140611 | 0 | |
| 103844203 | 10384420 | 12 | 20140612 | 0 | ||
| 103844203 | 10384420 | 13 | 2006 | 0 | ||
| 103844203 | 10384420 | 14 | 2006 | 0 | ||
| 103844203 | 10384420 | 15 | 20140401 | 20140722 | 0 | |
| 103844203 | 10384420 | 16 | 20140330 | 20140722 | 0 | |
| 103844203 | 10384420 | 17 | 20140331 | 20140721 | 0 | |
| 103844203 | 10384420 | 18 | 20140401 | 20140722 | 0 |